Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (261-270 of 426) with videos related to

Pageof 43
Sort By:
Cardiovascular Diabetology|April 6, 2017
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialGian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, et al.
Nutrients|February 11, 2023
Gastrointestinal Manifestations and Low-<i>FODMAP</i> Protocol in a Cohort of Fabry Disease Adult PatientsGiorgia Gugelmo, Nicola Vitturi, Francesco Francini-Pesenti, et al.
Nutrients|March 12, 2022
Anthropometrics, Dietary Intake and Body Composition in Urea Cycle Disorders and Branched Chain Organic Acidemias: A Case Study of 18 Adults on Low-Protein DietsGiorgia Gugelmo, Livia Lenzini, Francesco Francini-Pesenti, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonistsVeronica Sciannameo, Paola Berchialla, Emanuela Orsi, et al.
Case Reports in Medicine|July 19, 2011
Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma)Gian Paolo Fadini, Alberto Maran, Anna Valerio, et al.
The Lancet Regional Health. Europe|October 27, 2025
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational studyGian Paolo Fadini, Andrea Giaccari, Fabio Broglio, et al.
Antioxidants & Redox Signaling|September 20, 2021
Hematopoietic and Nonhematopoietic <i>p66Shc</i> Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in DiabetesMattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, et al.
Stem Cells Translational Medicine|June 3, 2020
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trialBenedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 7, 2007
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic studyPaolo Tessari, Anna Coracina, Lucia Puricelli, et al.
Diabetes|May 21, 2010
Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathyPaolo Tessari, Diego Cecchet, Alessandra Cosma, et al.
Pageof 43

Showing results (261-270 of 426) with videos related to

Sort By:
Pageof 43
Cardiovascular Diabetology|April 6, 2017
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialGian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, et al.
Nutrients|February 11, 2023
Gastrointestinal Manifestations and Low-<i>FODMAP</i> Protocol in a Cohort of Fabry Disease Adult PatientsGiorgia Gugelmo, Nicola Vitturi, Francesco Francini-Pesenti, et al.
Nutrients|March 12, 2022
Anthropometrics, Dietary Intake and Body Composition in Urea Cycle Disorders and Branched Chain Organic Acidemias: A Case Study of 18 Adults on Low-Protein DietsGiorgia Gugelmo, Livia Lenzini, Francesco Francini-Pesenti, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonistsVeronica Sciannameo, Paola Berchialla, Emanuela Orsi, et al.
Case Reports in Medicine|July 19, 2011
Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma)Gian Paolo Fadini, Alberto Maran, Anna Valerio, et al.
The Lancet Regional Health. Europe|October 27, 2025
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational studyGian Paolo Fadini, Andrea Giaccari, Fabio Broglio, et al.
Antioxidants & Redox Signaling|September 20, 2021
Hematopoietic and Nonhematopoietic <i>p66Shc</i> Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in DiabetesMattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, et al.
Stem Cells Translational Medicine|June 3, 2020
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trialBenedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 7, 2007
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic studyPaolo Tessari, Anna Coracina, Lucia Puricelli, et al.
Diabetes|May 21, 2010
Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathyPaolo Tessari, Diego Cecchet, Alessandra Cosma, et al.
Pageof 43